E. Douglas KRAMER

City:

Stamford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2023-06-08

Top Assignees for applications by E. Douglas KRAMER

The entities that hold a legal rights for patent applications filed by inventor KRAMER E. Douglas:

Athenex HK Innovative Limited 3 Sha Tin, Hong Kong
Athenex, Inc. 1 Buffalo, NY United States
ATNX SPV, LLC 1 Buffalo, NY United States

Recent patent applications by KRAMER E. Douglas

E. Douglas KRAMER from Stamford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-08

US20230172942A1

Human necessities

METHODS OF TREATING AND/OR PREVENTING ACTINIC KERATOSIS

#2 | 2023-06-08

US20230172926A1

Human necessities

THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER

#3 | 2023-02-16

US20230046869A1

Human necessities

THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED DOCETAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER

#4 | 2021-09-23

US20210290614A1

Human necessities

Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer

#5 | 2020-06-25

US20200197405A1

Human necessities

Methods of treating and/or preventing actinic keratosis

#6 | 2020-06-18

US20200188386A1

Human necessities

Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer

#7 | 2020-06-18

US20200188363A1

Human necessities

Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer

#8 | 2018-09-13

US20180256589A1

Human necessities

Methods of treating and/or preventing actinic keratosis

#9 | 2018-07-26

US20180207148A1

Human necessities

THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER

InventorID:

2249988 ⎘